text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

TCI Chemistry News

August 2022

TCI offers an extensive catalog of 31,000 high-quality organic reagents suitable for benchtop-to-bulk chemistry. This issue covers our chemistry topics as follows:


New Reagent for Synthesis of Primary Sulfonamides: <i>t</i>BuONSO

New Reagent for Synthesis of Primary Sulfonamides: tBuONSO

In the field of medicinal chemistry, sulfonamide moiety is a common substructure and plays an important role for biological activity. Sulfonamides can be utilized as bioisosteres of carboxylic acids owing to their structural similarity and an acidic proton. tBuONSO [U0150] has been reported to undergo nucleophilic attack by Grignard reagents and organolithium reagents to give primary sulfonamides. This method is widely applicable to a variety of substrates like tertiary amines and hetero aromatic compounds, which are sensitive to oxidative conditions. Pseudouridines: Key Component of mRNA Medicine

Pseudouridines: Key Component of mRNA Medicine

Recently, mRNA medicines that generate specific proteins in target cells have received a lot of attention. Application of mRNA medicines are expected for not only vaccine but also protein replacement therapy, regenerative medicine, and gene-editing therapy by expression antigens, enzymes, signal proteins and more. In translation of mRNA into protein in target cell, 1-methylpseudouridine (m1Ψ) [M3387] and pseudouridine (Ψ) [P2939] are read like uridine (U), enhancing immune evasion and protein production. TCI offers 1-methylpseudouridine and pseudouridine by chemical synthesis, and can also supply these products in bulk quantities or synthesize the derivatives. C-H Arylation of N -Heteroarene Using a Photoredox Catalyst

TCI Practical Example: C-H Arylation of N-Heteroarene Using a Photoredox Catalyst

We are proud to present the C-H arylation of caffeine with 4-methoxybenzenediazonium tetrafluoroborate by using tris(2,2'-bipyridyl)ruthenium(II) chloride hexahydrate [T1655] as a photoredox catalyst. TCI has many visible light photoredox catalysts for photoreaction. One-Pot Palladium-Catalyzed Fluorosulfonylation of an Aryl Bromide Using DABSO and NFSI

TCI Practical Example: One-Pot Palladium-Catalyzed Fluorosulfonylation of an Aryl Bromide Using DABSO and NFSI

TCI introduces the synthetic protocol of 4-biphenylsulfonyl fluoride from 4-bromobiphenyl using DABSO [B3960] , NFSI [F0335] as reactants, and PdCl 2 (Amphos) 2 [B6255] as a palladium catalyst. You can see the other reaction examples using DABSO in TCI product brochure . » TCI eNewsletter Back Issues

Follow Us on Social Media

Facebook Instagram LinkedIn Twitter

How to Order TCI Products

To order, please contact your local distributor found below.

» Our distributors

* The prices displayed in the landing website are USD based catalog prices. TCI has specific website and local currency based price list for customers in South Korea, Singapore, and Australia. For customers in other Asia Pacific countries / regions, please visit our Asia Pacific Website and contact our local distributors for the end user's cost. (The USD prices that are shown in Asia Pacific websites are TCI's catalog prices.)
Please visit each country/region's website from the following links and confirm the prices. https://www.TCIchemicals.com

If you are interested in our biweekly e-enewsletter "TCI News" and want to receive regularly, please click the link below and sign up.
TCI News Sign-Up

Tokyo Chemical Industry Co., Ltd. (TCI)
Global Business Department
Customer Support and Technical service

» globalbusiness@TCIchemicals.com
» https://www.TCIchemicals.com
Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.